Tag: Programmed cell death protein 1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Programmed cell death protein 1

LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for ...

Added to Collection on: 2025-03-04 22:08:01

Tags for this article:

Immunology
Immune system
T cells
Cell biology
Lymphatic system
Cell-mediated immunity
Programmed cell death protein 1
T helper cell
Interferon gamma
Tumor microenvironment
Dendritic cell

Click the tags to see associated articles and topics

View Article Details
Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed ...

Added to Collection on: 2025-03-07 13:56:02

Tags for this article:

Biotechnology
Cancer vaccines
Immune system
Genomics
Medical genetics
Antigen
Cancer vaccine
MRNA vaccine
Vaccine
Immunotherapy
Programmed cell death protein 1
Individualized cancer immunotherapy
1952.HK
Everest Medicines
China
peking university cancer hospital
EvereST S

Click the tags to see associated articles and topics

View Article Details
Novel immune drug combination induces tumour microenvironment remodelling and ...

Added to Collection on: 2025-03-15 10:08:03

Tags for this article:

Immunology
T cells
Immune system
Clusters of differentiation
Lymphocytes
TOX
TIGIT
PD-L1
Programmed cell death protein 1
TREM2
HAVCR2
Tumor microenvironment

Click the tags to see associated articles and topics

View Article Details
Therapeutic Antibodies, Biosimilars & RNA Therapy Sales Report - GlobeNewswire

Added to Collection on: 2025-03-19 12:23:35

Tags for this article:

Immunology
Immune system
Biotechnology
Clusters of differentiation
Monoclonal antibodies
Biopharmaceutical
Antibody
TNF inhibitor
Programmed cell death protein 1
Biosimilar
Lymphocyte-activation gene 3
Tumor necrosis factor

Click the tags to see associated articles and topics

View Article Details
BeiGene has terminated the clinical development program of the TIGIT antibody osperlimab ...

Added to Collection on: 2025-04-04 13:50:45

Tags for this article:

TIGIT
Orphan drugs
Monoclonal antibodies
Immune system
BeiGene
Programmed cell death protein 1
Tislelizumab
Cancer immunotherapy
Immunotherapy
Compugen Ltd.
Ieramilimab

Click the tags to see associated articles and topics

View Article Details
Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2 ... - Nature

Added to Collection on: 2025-04-11 20:37:13

Tags for this article:

Immune system
Clusters of differentiation
T cells
Immunology
Breast cancer
HER2
Regulatory T cell
FOXP3
Immune checkpoint
PD-L1
Programmed cell death protein 1
Checkpoint inhibitor

Click the tags to see associated articles and topics

View Article Details
Gilead's Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer

Added to Collection on: 2025-04-22 12:52:10

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Ivonescimab
Triple-negative breast cancer
Antibody-drug conjugate
Sacituzumab govitecan
Vascular endothelial growth factor
Pembrolizumab
Non-small-cell lung cancer
Programmed cell death protein 1
Bispecific monoclonal antibody
Merck
Gilead

Click the tags to see associated articles and topics

View Article Details
Blocking a surprising master regulator of immunity eradicates liver tumors in mice

Added to Collection on: 2025-04-24 18:16:43

Tags for this article:

Clusters of differentiation
Immune system
Cytokines
Erythropoietin
Programmed cell death protein 1
Macrophage
E-selectin
Erythropoietin in neuroprotection
Tumor microenvironment

Click the tags to see associated articles and topics

View Article Details
PD-1 NSCLC Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by ...

Added to Collection on: 2025-05-06 00:52:00

Tags for this article:

Cancer immunotherapy
Lung cancer
Immune system
Orphan drugs
Antineoplastic drugs
PD-1 and PD-L1 inhibitors
Checkpoint inhibitor
Atezolizumab
Ivonescimab
Non-small-cell lung cancer
Targeted therapy
Programmed cell death protein 1
Non-Small Cell Lung Cancer Companies

Click the tags to see associated articles and topics

View Article Details
Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 ...

Added to Collection on: 2025-05-08 13:53:37

Tags for this article:

Immune system
Clusters of differentiation
Cancer immunotherapy
Virotherapy
Immunotherapy
PD-L1
Programmed cell death protein 1
Checkpoint inhibitor
TPBG
Bispecific monoclonal antibody
PD-1 and PD-L1 inhibitors
Aptevo Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Book a Demo